Search

everythinglearnresearchcommunity

for

Search:↓

A woman's severe insulin resistance improved with treatment, but she still had high testosterone levels due to ovarian issues.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Centratherum anthelminticum seed extract effectively treats Polycystic Ovary Syndrome in rats.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

Certain metabolites can either protect against or increase the risk of hair loss.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.

Testosterone increases sexual behavior in female capuchin monkeys.

Losing weight and taking birth control pills can greatly improve severe male hormone excess in women with PCOS.

Blood tests can detect ovarian Leydig cell tumors when scans don't, and surgery can confirm and treat these tumors.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

The document concludes that personalized treatment, including lifestyle changes and medication, is essential for managing PCOS in teenagers, while also addressing their psychological well-being.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

Woman with diabetes had hair loss due to rare ovarian tumor; surgery improved hair growth.

A woman's high testosterone levels and related symptoms improved after ovary removal surgery.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.